Works matching IS 21644403 AND DT 2019 AND VI 9 AND IP 10
Results: 8
Formal Hereditary Cancer Genetic Counseling Improves Patient Outcomes.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 10, p. 23
- By:
- Publication type:
- Article
FDA Approves Inrebic for the Treatment of Patients with Myelofibrosis.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 10, p. 26
- Publication type:
- Article
The Pediatric MATCH Study: Actionable Targets Found in 25% of Young Patients with Cancer.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 10, p. 22
- By:
- Publication type:
- Article
Single-Agent ONC201 Induces Responses in Patients with Hard-to-Treat Recurrent High-Grade Glioma.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 10, p. 19
- By:
- Publication type:
- Article
Neoantigens Are Effective Targets for Developing Cancer Vaccines.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 10, p. 18
- By:
- Publication type:
- Article
BLU-667, Selective RET Inhibitor, Demonstrates Antitumor Activity in NSCLC with RET Fusion.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 10, p. 1
- By:
- Publication type:
- Article
Engaging Patients in Their Cancer Care Through Digital Health.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 10, p. 1
- By:
- Publication type:
- Article
2019 Fall Tips: USP, OSHA, and Practice Protection.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 10, p. 1
- By:
- Publication type:
- Article